Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Endocrinology
•
Bone and Calcium Disorders
Which osteoporosis medication is best at improving bone density and hence fracture risk in the wrist?
Related Questions
What is the recommended duration of Burosumab therapy for treating X-linked hypophosphatemia and how is response to therapy monitored?
What can cause a vertebra to be hyperdense on bone density testing and thus excluded other than vertebral fracture or degenerative change?
Should we aim to reduce or stop thiazides in patients with thiazide-induced hypercalcemia given its similar risk profile to untreated primary hyperparathyroidism?
Would you offer bisphosphonate therapy for infants with osteogenesis imperfecta type 11?
Do you use bone turnover markers to assess medical adherence in patients treated for osteoporosis?
What is the recommended workup for PTH-independent hypercalcemia secondary to an elevated 1,25-dihydroxyvitamin D level?
What is the optimal vitamin D level for pregnant women for maternal and fetal health and how should this be supplemented in pregnancy?
Are SGLT2 inhibitors contraindicated in patients with osteoporosis and history of vertebral and hip fractures?
How long can you delay the start of antiresorptive therapy after completion of anabolic therapy in patients with severe osteoporosis and recent invasive dental procedures?
When interpreting bone density reports, are T-scores adjusted for different age brackets?
